Staff Data Search - جامعة الزقازيق

/ Staff Data Search - جامعة الزقازيق

Not Found

Personal Website

Heba Fekry Abdel Majid Taha

Faculty Medicine - Department Oncology

Scientific degrees

BSc In , [1999]
MSc In NULL, [2005]
(Evaluation of P-Glycoprotein over-Expression in refractory and relapsed nhl and response to mine protocol /)
PhD In NULL, [2012]

الحالة الوظيفية الحالية :

قائم بالعمل

Academic Jobs

معيد : 3/3/2005
Doctor Assisant : 15/3/2006
Doctor : 30/10/2012
Professor Assisant : 31/3/2020

Publications

1 - Combined Ezrin overexpression and E-cadherin downregulation as predictors of invasiveness, higher incidence of metastases, progression and poor prognosis in patients with cervical cancer (2018).

2 - The Value of FAK and SLUG Expression in Patients with Breast Carcinoma and Relation of Their Expression to Clinicopathological and Prognostic Parameters (2018).

3 - SPOP, ZEB-1 and E-cadherin expression in clear cell renal cell carcinoma (cc-RCC): Clinicopathological and prognostic significance (2018).

4 - Prognostic values and clinical implications of programmed cell death-ligand 1 (PD-L1), fork head transcription factor P-1 (FOXP-1) and signal transducer and activator of transcription-3 (STAT-3) expression in diffuse large B-cell lymphoma (DLBCL); an immunohistochemical study. (2019).

5 - The diagnostic role of Arginase1, MOC31, and CDX2 in the differentiation of hepatocellular carcinoma, cholangiocarcinoma and metastatic colonic carcinoma of the liver (2019).

6 - Concordance between ER, PR, HER-2 neu Receptors Before and after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (2020).

7 - Clinical, pathological and prognostic implications of USP22, SIRT1 and Ecadherin expression in papillary thyroid cancer (PTC) and adjacent non-neoplastic tissue (2019).

8 - Prognostic and Clinic-Pathological Significances of SCF and COX-2 Expression in Inflammatory and Malignant Prostatic Lesions (2018).

9 - Prognostic and Clinic-Pathological Significances of SCF and COX-2 Expression in Inflammatory and Malignant Prostatic Lesions (2018).

Research Area